Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS)

46 filings reported holding MRUS - Merus N.V. - Common Shares, Euro 0.09 nominal value per share as of Q2 2020.
Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 18,590,455 shares of 75,893,250 outstanding shares and own 24% of the company stock.
Largest 10 shareholders include BVF INC/IL (5,090,571 shares), FEDERATED HERMES, INC. (2,439,196 shares), BAKER BROS. ADVISORS LP (2,037,469 shares), Medicxi Ventures Management (Jersey) Ltd (1,600,000 shares), Sofinnova Investments, Inc. (1,311,039 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (820,925 shares), WELLINGTON MANAGEMENT GROUP LLP (753,304 shares), MPM Oncology Impact Management LP (700,879 shares), HILLHOUSE CAPITAL ADVISORS, LTD. (600,000 shares), and Cormorant Asset Management, LP (600,000 shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.